Wendy Chang
Personalreferent bei HARPOON THERAPEUTICS, INC.
Profil
Wendy Chang is currently the Chief People Officer at Harpoon Therapeutics, Inc. She previously worked at IDbyDNA, Inc. as the Head of People & Culture.
Ms. Chang completed her undergraduate degree at the University of California.
Aktive Positionen von Wendy Chang
| Unternehmen | Position | Beginn |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Personalreferent | 06.07.2022 |
Ehemalige bekannte Positionen von Wendy Chang
| Unternehmen | Position | Ende |
|---|---|---|
IDbyDNA, Inc.
 IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Personalreferent | - |
Ausbildung von Wendy Chang
| University of California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HARPOON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Health Technology |
